Grand Challenges in Neuroscience

A screenshot from a virtual webinar or video call hosted by StarFish Medical. On the left, a man labeled 'Nick Allan' is wearing a headset and laughing, sitting in an open office space with multiple computer monitors and employees in the background. On the right, a man labeled 'Dr. Jacob Hooker' is smiling while sitting in an office with large windows, framed pictures, and artwork behind him.
Resources

Grand Challenges in Neuroscience

Authors: Nick Allan
Topic: Webinar

Advancements in neuroscience are reshaping our understanding of the human brain, but significant challenges remain in translating scientific breakthroughs into effective treatments. From overcoming the blood-brain barrier to developing more precise drug delivery methods, researchers and engineers are working to bridge the gap between discovery and patient impact.

In the webinar “Grand Challenges in Neuroscience” from January 21, 2025, Dr. Jacob Hooker, Lurie Family Professor of Radiology and Scientific Director at the Lurie Center for Autism at Massachusetts General Hospital, joins Nick Allan, Bio Services Manager at StarFish Medical, to discuss some of the biggest hurdles in neuroscience today. The conversation explores the complex interplay between chemistry, biology, and medical device engineering, offering insights into the latest innovations in neurotherapeutics, molecular imaging, and non-invasive drug delivery technologies.

Dr. Hooker shares his expertise in using positron emission tomography (PET) and functional MRI to study the molecular mechanisms of brain function and disease. He discusses how cutting-edge imaging techniques are unlocking new ways to diagnose and treat neurological disorders, neurodegenerative diseases, and psychiatric conditions. These tools address some grand challenges in modern neuroscience research.

A major focus of the discussion is the blood-brain barrier, a protective mechanism that makes it difficult to deliver therapeutics directly to the brain. The speakers examine novel strategies to bypass this challenge, including focused ultrasound, molecular engineering, and olfactory-based drug delivery systems. They also explore how medical device innovation plays a crucial role in advancing cell and gene therapy delivery, ensuring safety and efficacy while minimizing risk.

Beyond drug delivery, the webinar covers the growing role of wearables and real-time monitoring technologies in neuroscience. The potential for home-administered or regionally accessible treatments is expanding, with new engineering solutions making these approaches more feasible. Addressing these grand challenges in neuroscience is revolutionizing treatment accessibility.

The discussion also touches on the future of mental health treatments, emerging research in ALS and neurodegenerative disease, and the role of molecular glues and genetic therapies in addressing complex neurological conditions.

Whether you’re involved in medical device development, neuroscience research, or healthcare innovation, this webinar provides invaluable insights into the evolving landscape of brain health technologies.

Alt text: Two men are pictured side by side, both smiling, against a white background. In the top left corner is the StarFish Medical logo with the word "WEBINAR" written below it in purple text. The man on the left has short dark hair and is wearing a white shirt with a black sweater. The man on the right has short brown hair, a beard, and is wearing a green and blue plaid shirt.

Grand Challenges in Neuroscience

Solving mysteries of the human brain with drug delivery

Watch the recording
Alcohol disrupting bacterial cell membrane explaining why 70 percent sanitizer kills bacteria more effectively

Why 70% Alcohol Sanitizer Works Better Than 100%

Nick and Nigel explore the science behind hand sanitizer formulations. They discuss how alcohol interacts with bacterial cells, why water improves its effectiveness, and what the additional ingredients in sanitizer actually do.

Scott Phillips of StarFish Medical and Peter van der Velden of Lumira Ventures speaking at a MedTech transactions webinar

Behind the Deal: Inside Major MedTech Transactions

Scott Phillips, CEO of StarFish Medical, sits down with Peter van der Velden, Managing General Partner at Lumira Ventures, to explore the strategic thinking behind major MedTech transactions and investments.

AI analyzing MRI brain scan using computer vision software on a medical imaging workstation

Computer Vision: Attention or Convolution?

Computer vision technologies such as convolutional neural networks and vision transformers are transforming how AI analyzes medical images, each offering distinct advantages depending on the application and computing environment.

MedTech engineers discussing prototype strategy while demonstrating a medical device form prototype during product development.

Proof of Concept Prototypes in Medical Device Development

Ariana and Mark explore how prototype strategy helps teams reduce technical risk and accelerate progress.